M
Maxine S. Jochelson
Researcher at Memorial Sloan Kettering Cancer Center
Publications - Â 139
Citations - Â 5270
Maxine S. Jochelson is an academic researcher from Memorial Sloan Kettering Cancer Center. The author has contributed to research in topics: Breast cancer & Mammography. The author has an hindex of 37, co-authored 117 publications receiving 4160 citations. Previous affiliations of Maxine S. Jochelson include Cornell University & Cedars-Sinai Medical Center.
Papers
More filters
Journal ArticleDOI
Bilateral contrast-enhanced dual-energy digital mammography: feasibility and comparison with conventional digital mammography and MR imaging in women with known breast carcinoma.
Maxine S. Jochelson,D. David Dershaw,Janice S. Sung,Alexandra S. Heerdt,Cynthia M Thornton,Chaya S. Moskowitz,Jessica Ferrara,Elizabeth A. Morris +7 more
TL;DR: Bilateral dual-energy contrast agent-enhanced digital mammography was feasible and easily accomplished and was used to detect known primary tumors at a rate comparable to that of MR imaging and higher than that of conventionaldigital mammography.
Journal ArticleDOI
Identification of major prognostic subgroups of patients with large-cell lymphoma treated with m-BACOD or M-BACOD.
Margaret A. Shipp,David P. Harrington,Mary M. Klatt,Maxine S. Jochelson,Geraldine S. Pinkus,Jessica L. Marshall,David S. Rosenthal,Arthur T. Skarin,George P. Canellos +8 more
TL;DR: Patients with diffuse large-cell lymphoma treated with m- or M-BACOD were evaluated for pretreatment characteristics predictive for response and survival and two characteristics, poor performance status and massive bulky disease, were negatively associated with response rate in a multivariate analysis.
Journal ArticleDOI
Malignant pleural mesothelioma: value of CT and MR imaging in predicting resectability.
Edward F. Patz,Kitt Shaffer,D R Piwnica-Worms,Maxine S. Jochelson,M. Sarin,David J. Sugarbaker,Robert D. Pugatch +6 more
TL;DR: CT and MR provided similar information on resectability in most cases, and CT is more widely available and used than MR as the initial study when determining resectabilities.
Journal ArticleDOI
Gallium-67 imaging: a predictor of residual tumor viability and clinical outcome in patients with diffuse large-cell lymphoma.
William D. Kaplan,Maxine S. Jochelson,Terence S. Herman,Lee M. Nadler,P C Stomper,Tak Takvorian,Janet Andersen,George P. Canellos +7 more
TL;DR: Ga-67 imaging proved to be an excellent indicator of residual viable tumor; a positive scan halfway through therapy predicted for a poor outcome and may well justify a change in treatment.
Journal ArticleDOI
Abbreviated protocol for breast MRI: Are multiple sequences needed for cancer detection?
Victoria L. Mango,Victoria L. Mango,Elizabeth A. Morris,D. David Dershaw,Andrea F. Abramson,Charles Fry,Charles Fry,Chaya S. Moskowitz,Mary Hughes,Jennifer B. Kaplan,Maxine S. Jochelson +10 more
TL;DR: One pre and post-contrast T1W sequence may be adequate for detecting breast carcinoma and these results support the possibility of refining breast MRI screening protocols.